BioSpace News Archive

The U.S. Food and Drug Administration has updated a safety communication on reprocessed flexible bronchoscopes.

ERYTECH Pharma announced that its 2021 Annual General Meeting was held in Lyon on Friday, June 25, 2021.

Hepion Pharmaceuticals, Inc. today announced that its 2021 Annual Meeting of Stockholders, scheduled for June 25, 2021, has been adjourned due to a lack of quorum. The adjourned meeting will be held at 9:00 a.m. Eastern Time on Friday, July 23, 2021.

IR-Med, Inc. (OTCPINK: IRME) announced today the appointment of Dr. Rom Eliaz as Chief Executive Officer.

BIOASIS TECHNOLOGIES INC. announced it has filed its audited annual financial statements and management’s discussion and analysis for the period ended February 28, 2021.

Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, joins the broad-market Russell 2000® and 3000® Indices effective after the US market opens on June 28.

Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a privately-held clinical-stage biopharmaceutical company developing autologous and allogeneic Natural Killer (NK) cellular and antibody therapeutics announced that Robert Brooks, JD, founder and Chief Executive Officer of Alphageneron, will participate in the ROTH Healthcare Private Company Forum